Akt phosphorylation was activated by cisplatin in a dose-dependent manner in the HCC cell lines with Pyk2 over-expression (MHCC97L-vector, PLC-Pyk2 and Hep3B-Pyk2). Here, AKT1 is linked to hepatocellular carcinoma.